Work

Preclinical Study on the Antidepressant Activity of Lagenaria siceraria Leaf Extract Using Forced Swim and Tail Suspension Models

Year: 2026
Type: article
Abstract: Depression is a globally prevalent neuropsychiatric disorder that significantly impairs quality of life and poses a major public health burden. Despite advances in pharmacotherapy, current antidepressant drugs are associated with numerous adverse effects, high costs, and delayed therapeutic onset, which necessitates the exploration of safer herbal alternatives. Lagenaria siceraria (Molina) Standl. (family Cucurbitaceae), commonly known as bottle gourd, has been used extensively in traditional medicine for the management of various ailments including nervous disorders, stress, and anxiety. This review comprehensively examines the preclinical evidence supporting the antidepressant activity of L. siceraria leaf extract, with a particular focus on the two most widely validated behavioral despair models: the Forced Swim Test (FST) and the Tail Suspension Test (TST). The phytochemical constituents of the plant — including flavonoids, saponins, alkaloids, phenolic acids, and sterols — are discussed in relation to their potential mechanisms of antidepressant action involving serotonergic, noradrenergic, and dopaminergic neurotransmitter pathways. Evidence from multiple in vivo studies demonstrates significant reduction in immobility time in both FST and TST paradigms following oral administration of L. siceraria leaf extracts across various doses and solvent systems. The review also discusses methodological considerations, limitations of preclinical models, and the potential for future clinical translation. Collectively, available data supports L. siceraria leaf extract as a promising candidate for the development of novel antidepressant phytotherapy.
Author: Usha Kanyal
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7217812144
FWCI:
Cites: 35
Cited by:
Related to: 10